Catalyst Pharmaceuticals (CPRX) Cash from Financing Activities (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Cash from Financing Activities of -$12.9 million for Q1 2026, down 520.65% year-on-year from $3.1 million in Q1 2025, and up 49.68% on a QoQ basis from -$25.6 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 16 years of Cash from Financing Activities data on file, last reported at -$12.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 520.65% year-over-year to -$12.9 million; the trailing twelve-month figure through Mar 2026 stood at -$32.9 million (down 1330.42% YoY), and the FY2025 full-year result was -$17.0 million, down 112.08% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$12.9 million, up from -$25.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $141.0 million in Q1 2024 and bottomed at -$25.6 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is $149000.0 (2023), against an average of $6.0 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities slumped 925.0%; it then surged 94563.76% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $2.3 million in 2022, then plunged by 129.52% to -$665000.0 in 2023, then surged by 766.62% to $4.4 million in 2024, then plunged by 677.04% to -$25.6 million in 2025, then surged by 49.68% to -$12.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$12.9 million (Q1 2026), -$25.6 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -12.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.87 Mn |
| Mar 31, 2026 | -12.87 Mn |
| Dec 31, 2025 | -25.58 Mn |
| Dec 31, 2025 | -25.58 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Jun 30, 2025 | 872,000.00 |
| Jun 30, 2025 | 872,000.00 |
| Mar 31, 2025 | 3.06 Mn |
| Mar 31, 2025 | 3.06 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | -5.97 Mn |
| Sep 30, 2024 | -5.97 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 141.05 Mn |
| Mar 31, 2024 | 141.05 Mn |
| Dec 31, 2023 | -665,000.00 |
| Dec 31, 2023 | -665,000.00 |
| Sep 30, 2023 | -10.13 Mn |
| Sep 30, 2023 | -10.13 Mn |
| Jun 30, 2023 | -214,000.00 |
| Jun 30, 2023 | -214,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 2.25 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | -2.99 Mn |
| Jun 30, 2022 | -2.99 Mn |
| Mar 31, 2022 | -1.55 Mn |
| Mar 31, 2022 | -1.55 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Sep 30, 2021 | -2.10 Mn |
| Sep 30, 2021 | -2.10 Mn |
| Jun 30, 2021 | -3.71 Mn |
| Jun 30, 2021 | -3.71 Mn |
| Mar 31, 2021 | 188,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 26,000.00 |
| Dec 31, 2020 | 26,000.00 |
| Sep 30, 2020 | 614,000.00 |
| Sep 30, 2020 | 614,000.00 |
| Jun 30, 2020 | 36,000.00 |
| Jun 30, 2020 | 36,000.00 |
| Mar 31, 2020 | 26,000.00 |
| Mar 31, 2020 | 26,000.00 |
| Dec 31, 2019 | 578,038.00 |
| Dec 31, 2019 | 578,038.00 |
| Sep 30, 2019 | 256,062.00 |
| Sep 30, 2019 | 256,062.00 |
| Jun 30, 2019 | 192,550.00 |
| Jun 30, 2019 | 192,550.00 |
| Mar 31, 2019 | 89,350.00 |
| Mar 31, 2019 | 89,350.00 |
| Dec 31, 2018 | 151,499.00 |
| Dec 31, 2018 | 151,499.00 |
| Sep 30, 2018 | 104,532.00 |
| Sep 30, 2018 | 104,532.00 |
| Jun 30, 2018 | 4,052.00 |
| Jun 30, 2018 | 4,052.00 |
| Mar 31, 2018 | 33,032.00 |
| Mar 31, 2018 | 33,032.00 |
| Dec 31, 2017 | 54.14 Mn |
| Dec 31, 2017 | 54.14 Mn |
| Sep 30, 2017 | 1.41 Mn |
| Sep 30, 2017 | 1.41 Mn |
| Dec 31, 2016 | 80,251.00 |
| Dec 31, 2016 | 80,251.00 |
| Mar 31, 2016 | -11,265.00 |
| Mar 31, 2016 | -11,265.00 |
| Dec 31, 2015 | 65,402.00 |
| Dec 31, 2015 | 65,402.00 |
| Sep 30, 2015 | 916,617.00 |
| Sep 30, 2015 | 916,617.00 |
| Jun 30, 2015 | 113,044.00 |
| Jun 30, 2015 | 113,044.00 |
| Mar 31, 2015 | 36.06 Mn |
| Mar 31, 2015 | 36.06 Mn |
| Dec 31, 2014 | 1.82 Mn |
| Dec 31, 2014 | 1.82 Mn |
| Jun 30, 2014 | 26.73 Mn |
| Jun 30, 2014 | 26.73 Mn |
| Mar 31, 2014 | 16,504.00 |
| Mar 31, 2014 | 16,504.00 |
| Dec 31, 2013 | 189,801.00 |
| Dec 31, 2013 | 189,801.00 |
| Sep 30, 2013 | 17.97 Mn |
| Sep 30, 2013 | 17.97 Mn |
| Dec 31, 2012 | 5.08 Mn |
| Dec 31, 2012 | 5.08 Mn |
| Sep 30, 2012 | 5.56 Mn |
| Sep 30, 2012 | 5.56 Mn |
| Dec 31, 2011 | 3.31 Mn |
| Dec 31, 2011 | 3.31 Mn |
| Mar 31, 2011 | 2.23 Mn |
| Mar 31, 2011 | 2.23 Mn |